
Solta Medical, Division of Bausch Health Companies Inc.
- Home
- Companies
- Solta Medical, Division of Bausch ...
- Products
- Clear+Brilliant - Non-ablative Laser ...
Clear+Brilliant - Non-ablative Laser for General Skin Resurfacing
The Clear + Brilliant system is a non-ablative laser for general skin resurfacing, which can help improve skin tone, texture, fine lines, and overall appearance of the skin, and reduce the appearance of pore size.
Most popular related searches
skin resurfacing
skin condition
dermal filler
hyaluronic acid
skin tone
blood stream
immune system
skin cancer
injectable dermal filler
skin sensitization
- The following contraindications are routine for many laser treatments and may also be associated with non-ablative Clear + Brilliant® laser system treatments. You may not be an appropriate candidate for a treatment if you:
- Have been diagnosed with or possibly have actinic keratosis, melasma, rosacea, or other significant skin conditions (e.g., skin cancer, active infections, cold sores, open wounds or a sore that has not or will not heal, rashes, burns, inflammation, eczema, psoriasis);
- Are predisposed to keloid formation or excessive scarring;
- Have a condition that may compromise the immune system, or your ability to fight infections, such as HIV, lupus, scleroderma, or infections in the blood stream;
- Have a known sensitivity to light or if you are taking any medications that may make your skin more sensitive to UV or artificial light;
- Are on oral/systemic steroids (e.g., prednisone, dexamethasone), which should be rigorously avoided prior to and throughout the course of treatment;
- Are using retinoids, which should be avoided for at least 2 weeks prior to and during treatment;
- Are undergoing isotretinoin acne treatment or taking drugs in a similar class;
- Have skin that is still recovering from a cosmetic procedure, such as a chemical or mechanical peel, or laser resurfacing; and
- Have had botulinum toxin injections, or dermal fillers (such as collagen or hyaluronic acid) within the past 2 weeks.